firocoxib has been researched along with Gait Disorders, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Beugnet, F; de Salazar Alcalá, AG; Dehman, A; Gioda, L | 1 |
| Bauck, AG; Gilliam, LL; Kembel, SL; Schoonover, MJ; Taylor, JD; Young, JM | 1 |
| Brain, PH; Dunn, AL; Greenwell, CM | 1 |
| Back, W; Hanson, PD; MacAllister, CG; Pollmeier, M; van Heel, MC | 1 |
| Joubert, KE | 1 |
| Asimus, E; Autefage, A; Palissier, FM; Pepin-Richard, C | 1 |
| Al-Nadaf, S; Budsberg, SC; Cathcart, CJ; Johnston, SA; Reynolds, LR | 1 |
| De Voe, RS; Linder, K; Loomis, MR; McCalla-Martin, A; Stringer, EM; Troan, B | 1 |
| Boston, RC; Carithers, DS; Orsini, JA; Ryan, WG | 1 |
| Alva, R; Bell, L; Brooks, KC; Case, J; Conzemius, M; Drag, M; Fleishman, C; Gordon, W; Hanson, PD; Romano, D; Schuessler, J; Shelley, B; Sifferman, R | 1 |
| Hanson, PD; Hazewinkel, HA; Pollmeier, M; Theyse, LF; van den Brom, WE | 1 |
| Drag, M; Hanson, PD; Kunkle, BN; Romano, D | 1 |
| Alva, R; Bertone, AL; Doucet, MY; Hanson, PD; Hendrickson, D; Hughes, F; Kunkle, B; Macallister, C; McClure, S; Reinemeyer, C; Romano, D; Rossier, Y; Sifferman, R; Vrins, AA; White, G | 1 |
10 trial(s) available for firocoxib and Gait Disorders, Animal
| Article | Year |
|---|---|
Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Dog Diseases; Dogs; Lameness, Animal; Random Allocation; Sulfones; Sulfonylurea Compounds; Uric Acid | 2019 |
Efficacy of orally administered gabapentin in horses with chronic thoracic limb lameness.
Topics: 4-Butyrolactone; Analgesics; Animals; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Female; Gabapentin; Horse Diseases; Horses; Lameness, Animal; Male; Sulfones | 2020 |
The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Female; Forelimb; Horse Diseases; Horses; Lameness, Animal; Male; Pressure; Sulfones | 2009 |
The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
Topics: 4-Butyrolactone; Aging; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Chemical Analysis; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Osteoarthritis; Pain; Severity of Illness Index; Sulfones; Treatment Outcome | 2009 |
Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
Topics: 4-Butyrolactone; Analgesia; Animals; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Indazoles; Injections, Intra-Articular; Lameness, Animal; Male; Phenylurea Compounds; Stifle; Sulfones; Synovitis; TRPV Cation Channels; Uric Acid | 2012 |
Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Cyclooxygenase 2 Inhibitors; Female; Horse Diseases; Horses; Lameness, Animal; Male; Musculoskeletal Pain; Osteoarthritis; Pain Management; Sulfones | 2012 |
Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Etodolac; Female; Lameness, Animal; Male; Osteoarthritis; Range of Motion, Articular; Safety; Sulfones; Treatment Outcome | 2006 |
Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Carbazoles; Cross-Over Studies; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Naphthalenes; Propionates; Sulfones; Synovitis; Time Factors; Uric Acid | 2008 |
Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
Topics: 4-Butyrolactone; Animals; Carbazoles; Cyclooxygenase 2 Inhibitors; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Meloxicam; Severity of Illness Index; Sulfonamides; Sulfones; Synovitis; Thiazines; Thiazoles; Treatment Outcome; Uric Acid | 2007 |
Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Horse Diseases; Horses; Lameness, Animal; Male; Osteoarthritis; Phenylbutazone; Range of Motion, Articular; Severity of Illness Index; Sulfones; Time Factors; Treatment Outcome | 2008 |
3 other study(ies) available for firocoxib and Gait Disorders, Animal
| Article | Year |
|---|---|
Metaphyseal osteopathy in three Australian Kelpie siblings.
Topics: 4-Butyrolactone; Animals; Australia; Bone Diseases, Developmental; Dog Diseases; Dogs; Fatal Outcome; Female; Histocytochemistry; Lameness, Animal; Male; Prednisolone; Radiography; Siblings; Sulfones | 2014 |
Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Osteoarthritis; Prospective Studies; Severity of Illness Index; Sulfones; Treatment Outcome | 2011 |
Vesiculobullous skin reaction temporally related to firocoxib treatment in a white rhinoceros (Ceratotherium simum).
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Female; Lameness, Animal; Perissodactyla; Skin Diseases, Vesiculobullous; Sulfones | 2012 |